Literature DB >> 32123087

SOX4-mediated repression of specific tRNAs inhibits proliferation of human glioblastoma cells.

Jianjing Yang1,2,3, Derek K Smith3,4, Haoqi Ni1,2,3, Ke Wu1,2, Dongdong Huang1,2, Sishi Pan1,2,3, Adwait A Sathe5, Yu Tang3,4, Meng-Lu Liu3,4, Chao Xing5,6,7, Chun-Li Zhang8,4, Qichuan Zhuge9,2.   

Abstract

Transfer RNAs (tRNAs) are products of RNA polymerase III (Pol III) and essential for mRNA translation and ultimately cell growth and proliferation. Whether and how individual tRNA genes are specifically regulated is not clear. Here, we report that SOX4, a well-known Pol II-dependent transcription factor that is critical for neurogenesis and reprogramming of somatic cells, also directly controls, unexpectedly, the expression of a subset of tRNA genes and therefore protein synthesis and proliferation of human glioblastoma cells. Genome-wide location analysis through chromatin immunoprecipitation-sequencing uncovers specific targeting of SOX4 to a subset of tRNA genes, including those for tRNAiMet Mechanistically, sequence-specific SOX4-binding impedes the recruitment of TATA box binding protein and Pol III to tRNA genes and thereby represses their expression. CRISPR/Cas9-mediated down-regulation of tRNAiMet greatly inhibits growth and proliferation of human glioblastoma cells. Conversely, ectopic tRNAiMet partially rescues SOX4-mediated repression of cell proliferation. Together, these results uncover a regulatory mode of individual tRNA genes to control cell behavior. Such regulation may coordinate codon usage and translation efficiency to meet the demands of diverse tissues and cell types, including cancer cells.

Entities:  

Keywords:  SOX4; glioblastoma; mRNA translation; tRNA expression; tRNAiMet

Year:  2020        PMID: 32123087      PMCID: PMC7084149          DOI: 10.1073/pnas.1920200117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  General repression of RNA polymerase III transcription is triggered by protein phosphatase type 2A-mediated dephosphorylation of Maf1.

Authors:  Danuta Oficjalska-Pham; Olivier Harismendy; Wieslaw J Smagowicz; Anne Gonzalez de Peredo; Magdalena Boguta; André Sentenac; Olivier Lefebvre
Journal:  Mol Cell       Date:  2006-06-09       Impact factor: 17.970

2.  Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells.

Authors:  Mariana Pavon-Eternod; Suzana Gomes; Marsha R Rosner; Tao Pan
Journal:  RNA       Date:  2013-02-19       Impact factor: 4.942

3.  A dual program for translation regulation in cellular proliferation and differentiation.

Authors:  Hila Gingold; Disa Tehler; Nanna R Christoffersen; Morten M Nielsen; Fazila Asmar; Susanne M Kooistra; Nicolaj S Christophersen; Lise Lotte Christensen; Michael Borre; Karina D Sørensen; Lars D Andersen; Claus L Andersen; Esther Hulleman; Tom Wurdinger; Elisabeth Ralfkiær; Kristian Helin; Kirsten Grønbæk; Torben Ørntoft; Sebastian M Waszak; Orna Dahan; Jakob Skou Pedersen; Anders H Lund; Yitzhak Pilpel
Journal:  Cell       Date:  2014-09-11       Impact factor: 41.582

4.  Initiator-elongator discrimination in vertebrate tRNAs for protein synthesis.

Authors:  H J Drabkin; M Estrella; U L Rajbhandary
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

5.  Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma.

Authors:  Biaoyang Lin; Anup Madan; Jae-Geun Yoon; Xuefeng Fang; Xiaowei Yan; Taek-Kyun Kim; Daehee Hwang; Leroy Hood; Gregory Foltz
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

6.  Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors.

Authors:  Pierre-Olivier Guichet; Ivan Bieche; Marisa Teigell; Ché Serguera; Bernard Rothhut; Valérie Rigau; Frédérique Scamps; Chantal Ripoll; Sophie Vacher; Sylvie Taviaux; Hugues Chevassus; Hugues Duffau; Jacques Mallet; Aurélie Susini; Dominique Joubert; Luc Bauchet; Jean-Philippe Hugnot
Journal:  Glia       Date:  2012-10-09       Impact factor: 7.452

Review 7.  Determinants of translation efficiency and accuracy.

Authors:  Hila Gingold; Yitzhak Pilpel
Journal:  Mol Syst Biol       Date:  2011-04-12       Impact factor: 11.429

8.  Small Molecules Modulate Chromatin Accessibility to Promote NEUROG2-Mediated Fibroblast-to-Neuron Reprogramming.

Authors:  Derek K Smith; Jianjing Yang; Meng-Lu Liu; Chun-Li Zhang
Journal:  Stem Cell Reports       Date:  2016-10-27       Impact factor: 7.765

9.  tRNA over-expression in breast cancer and functional consequences.

Authors:  Mariana Pavon-Eternod; Suzanna Gomes; Renaud Geslain; Qing Dai; Marsha Rich Rosner; Tao Pan
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

10.  Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons.

Authors:  Meng-Lu Liu; Tong Zang; Yuhua Zou; Joshua C Chang; Jay R Gibson; Kimberly M Huber; Chun-Li Zhang
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  4 in total

Review 1.  tRNA Function and Dysregulation in Cancer.

Authors:  Tania Gupta; Mark G Malkin; Suyun Huang
Journal:  Front Cell Dev Biol       Date:  2022-06-01

2.  Synonymous but Not Silent: The Codon Usage Code for Gene Expression and Protein Folding.

Authors:  Yi Liu; Qian Yang; Fangzhou Zhao
Journal:  Annu Rev Biochem       Date:  2021-01-13       Impact factor: 23.643

3.  Ferroptosis Activation Scoring Model Assists in Chemotherapeutic Agents' Selection and Mediates Cross-Talk With Immunocytes in Malignant Glioblastoma.

Authors:  Zeyu Wang; Ziyu Dai; Lifu Zheng; Binyuan Xu; Hao Zhang; Fan Fan; Xun Zhang; Xisong Liang; Zhixiong Liu; Kui Yang; Quan Cheng
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

Review 4.  Alternate Roles of Sox Transcription Factors beyond Transcription Initiation.

Authors:  Yuli Zhang; Linlin Hou
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.